North America Portable Ultrasound Bladder Scanner Market Size, Share & Trends Analysis Report By Product (2D and 3D), By End-use (Hospitals, Diagnostic Imaging Centers, and Others), By Country and Growth Forecast, 2024 - 2031

The North America Portable Ultrasound Bladder Scanner Market would witness market growth of 3.3% CAGR during the forecast period (2024-2031).

The US market dominated the North America Portable Ultrasound Bladder Scanner Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of$85.49 million by 2031. The Canada market is experiencing a CAGR of 5.5% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 4.6% during (2024 - 2031).



The applications of these scanners are diverse and encompass many clinical scenarios. These scanners are invaluable tools for diagnosing urinary retention, where the bladder fails to empty. By accurately measuring post-void residual urine volume, clinicians can identify patients at risk of complications such as urinary tract infections and renal impairment. This is particularly important in populations such as the elderly, patients with neurological disorders, or those recovering from surgery.

Furthermore, patients with neurogenic bladder dysfunction, spinal cord injuries, or neurological disorders often experience impaired bladder function, leading to issues like urinary retention or incontinence. These scanners enable regular bladder volume and function monitoring, facilitating timely intervention and management. This allows healthcare providers to adjust treatment plans and optimize patient care based on real-time bladder assessments.

Bladder cancer is one of the most commonly diagnosed cancers in Canada, with a significant burden on the healthcare system. Early detection is crucial for improving patient outcomes and survival rates. Bladder cancer is Canada's fifth most frequent cancer, according to the Government of Canada. It ranks 10th among women and 4th among males in frequency of occurrence. Bladder cancer will be identified in 1 in 22 males during their lives.

Throughout their lives, 1 in 75 women will receive a bladder cancer diagnosis. In 2020, approximately 12,200 Canadians were diagnosed with bladder cancer. Likewise, the rise in urological disorders such as urinary tract infections (UTIs), kidney stones, and bladder cancer in Mexico reflects a broader global trend driven by various factors, including lifestyle changes, aging populations, and increased awareness and diagnosis. In this context, diagnostic tools like portable ultrasound bladder scanners become imperative for accurate and noninvasive assessment of bladder function and urinary tract abnormalities. Thus, increasing bladder cancer and urological disorders in the region propels the market's growth.

Based on Product, the market is segmented into 2D and 3D. Based on End-use, the market is segmented into Hospitals, Diagnostic Imaging Centers, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• GE HealthCare Technologies, Inc.
• Koninklijke Philips N.V.
• Verathon Inc. (Roper Technologies, Inc.)
• Infinium Medical, Inc.
• Advin Health Care
• Caresono Technology Co.,Ltd.
• Becton, Dickinson and Company
• ECHO-SON S.A.
• Vitacon AS

Market Report Segmentation

By Product

• 2D
• 3D

By End-use

• Hospitals
• Diagnostic Imaging Centers
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America